The schedule presented here is subject to change as the agenda is finalized.
What happens when wisdom meets innovation, and lived experience meets digital fluency? This dynamic, intergenerational and interracial session explores how people across decades and racial identities navigate dating, disclosure, and desire in the age of PrEP, U=U, and mobile technology.
In collaboration with Columbia Psychiatry and New York Public Library, the community mental health project was created to address the impact of mental health on the Black and Afro-Latino communities in NYC, especially during and right after the COVID-19 pandemic. The intervention aims to engage the community in discussion around mental health and thus minimize stigma and advocate for innovative strategies to increase the utilization of mental health services within the community.
This session will provide an overview of how Deaf Community Advocacy Network (Deaf C.A.N.!) Deaf HIV Program addresses the unique challenges of PWLH who are Deaf, Deafblind, and Hard of Hearing navigating Ryan White Services. Through provider assessments and cultural competency training, client assessments and workshops to improve health literacy on HIV prevention and HIV treatment, and workshops for interpreters to increase their understanding of ever growing HIV terminology such as viral load suppression and U=U, Deaf C.A.N.! has expanded their case management services from 7 counties in the Detroit Metropolitan Area to the entire state of Michigan, increased partnerships, and improved client satisfaction
The purpose of this study is to address the health inequities among key populations living with HIV through a community-based participatory research (CBPR) mixed-methods study designed to adapt and pilot-test STEPS to Care (StC), a CDC-endorsed evidence-based intervention. This intervention consists of three person-centered, evidence-informed strategies to improve retention in HIV care, adherence to antiretroviral therapies, and reduce viral load, which include: Patient Navigation, Care Team Coordination, and HIV Self-Management.
In the US and globally, there have been two secular events exogenous to the HCV epidemic that has impacted HCV negatively. The first is well documented with the accompanying rise in the Opioid epidemic resulting in the uptick in HCV infections particularly among the population younger than the baby boomer generation. The second is the advent of COVID-19 that caused disruptions in testing, linkage and treatment of people living with Hepatitis C. We showcase the impact COVID 19 had on our testing program in Alabama.
This study aims to assess the follow-up eligibility of individuals with HCV presumed LTFU. Pre-contact investigation (PCI) to assess ineligibility, including due to death or outdated contact information, was encouraged. Data came from the patient registries of 23 of 30 grant-funded organizations in different clinical, community and geographical settings. Data sources included patient, state, prison, and public records.
This presentation traces the Ohio FOCUS HIV/HCV Partnership evolution, from early setbacks and outdated policies to transformative progress made possible through adaptive strategies, including the integration of a mobile testing model in partnership with Central Outreach Wellness Center. The model brought walk-in, judgment-free care directly to those most at risk, helping remove barriers to treatment. Additional partners, such as Ohio University, enhanced capacity through data coordination and evaluation.
The Target4 project partners with the University of Kentucky’s Bluegrass Care Clinic to integrate Hepatitis C telehealth services into syringe services programs throughout the commonwealth to address access barriers, improve treatment outcomes, and progress Hepatitis C elimination efforts in the Commonwealth. This presentation will discuss the process used to integrate telehealth services into the harm reduction environment in partnership with the local health departments, and share outcomes, successes, and lessons learned along the way.
This session includes an overview of LGBTQ+ reproductive health disparities, systemic barriers faced by LGBTQ+ clients navigating reproductive health services, and actionable steps organizations and providers can take to provide affirming, inclusive care.
This presentation offers a clinical and social work-centered approach to addressing the mental health needs of Black LGBTQIA+ men through trauma-informed, culturally responsive, and identity-affirming strategies. This session will explore how toxic stress stemming from early-life adversity impacts emotional regulation, relationship-building, and self-worth. Special emphasis will be placed on how systemic oppression, societal stigma, and the lack of culturally competent mental health services heighten these challenges.
This session will train health professionals to become effective advocates for gender-affirming care at the institutional, state, and federal levels. Amid growing legislative, administrative, and regulatory challenges to transgender health care, health professionals have a unique role and responsibility to advocate for inclusive, evidence-based policies. This session will provide participants with actionable tools to address barriers to care, counter misinformation, and build coalitions to support gender-affirming care access.
Hepatitis C virus (HCV) coinfection is associated with poor health outcomes for persons with HIV (PWH). Although higher HIV viral suppression rates have been reported among PWH who participate in Ryan White services, studies have not assessed effects on HCV coinfection.
The North Jersey Community Research Initiative (NJCRI) conducted a retrospective chart review to evaluate real-world utilization of oral and long-acting injectable PrEP (LA-Cabotegravir) among individuals accessing services between 2024 and 2025. NJCRI serves a predominantly Black and Brown, urban population in Newark, NJ, many of whom face housing instability, food insecurity, and limited access to affirming healthcare.
The U.S. has approved long-acting injectable PrEP options such as cabotegravir (Apretude) and lenacapavir (Yzugo), yet major challenges remain around equitable access, demand generation, and health-system readiness. This project explores what the United States can learn from low- and middle-income countries (LMICs) that successfully expanded injectable contraceptives, an intervention with striking parallels to injectable PrEP.
Since 2018, Texas has faced a steep rise in syphilis cases particularly among marginalized groups such as Hispanic and non-Hispanic Black individuals. These findings are parallel to HIV trends in Texas. This model merges surveillance with proactive prevention and clinical coordination, targeting individuals at heightened HIV risk. Ongoing data collection on patient demographics, barriers, and facilitators will optimize implementation and elevate prevention outcomes in underserved communities.
Strengthening OBGYN capacity to integrate PrEP into routine care is critical to reducing HIV incidence and advancing health equity for Black women in Mississippi. Findings will guide a forthcoming statewide, grant-funded initiative to scale PrEP delivery in women’s health settings, supporting the Ending the HIV Epidemic Initiative’s goals and addressing persistent disparities in HIV prevention access and outcomes.
This presentation explores replicable models of syndemic prevention in underserved Southern communities.
Recent data from the U.S estimated that over half (57%) of transgender women (TW), aged 50+, are living with HIV. Findings lacked analysis by age, gender, and race/ethnicity, but found 62% HIV prevalence among Black trans women, suggesting potential HIV disparities for older TW of color. This study focused on HIV outcomes and health services access for TW aged 50 and older, making important contributions to the context of care for this population sub-group, who shoulder disproportionately high HIV prevalence. Findings highlight the critical role of support services in HIV care engagement and the potential for expanded access and intergenerational peer support programs to ameliorate HIV-related disparities based on age and race.
In this session, participants will learn about the core elements of a community -based syndemic approach to HIV care engagement to enhance capacity to support PLWH throughout the HIV care continuum. This workshop will demonstrate how community health workers improve involvement in comprehensive prevention services.
This systematic review explores the role of CAB + RPV-LA injectables in antiretroviral therapy (ART), with a focus on patient-reported outcomes from five key clinical trials.
This session presents data from the National Substance Use and Mental Health Services Survey (2023) conducted by the Substance Abuse and Mental Health Services Administration to present the current state of availability of testing and treatment services for HIV, HCV, and STIs.
A translational research project implemented at a Sacramento County sexual health center to reduce barriers to Hepatitis C virus (HCV) treatment. To address elevated prevalence of Hepatitis C in the area, Sacramento County Public Health’s Sexual Health Clinic (SHC) opted to participate in a research project to develop and implement organizational supports and workflows to improve rates of HCV treatment for patients served in this setting.
Expanded screening for hepatitis C virus (HCV) infection aims to improve awareness of diagnosis, yet treatment uptake remains suboptimal due to structural, social, and individual-level barriers. People who use drugs face further challenges in accessing HCV treatment due to fragmented care, stigma, and limited support. Strategies to overcome these challenges are needed to improve health equity and achieve HCV elimination. We developed a quality improvement pilot project to integrate expedited DAA initiation, defined as prescribing of DAA during hospital admission.
The Department of Health and Human Services developed a National Strategic Plan to eliminate hepatitis C (HCV) as a public health threat by 2030. However, many barriers to accessing care remain. Pharmacists have increasingly played a role in the treatment of HCV and can support patients and care teams with navigating barriers at multiple steps along the care cascade. The Collaborative Drug Therapy Management (CDTM) model offers a strategy to leverage expertise of embedded pharmacists to improve HCV treatment access and outcomes.
Information on credits offered to SYNC participants for attending institutes, sessions, and plenaries — live or in-person — is available here.
This conference is supported, in part, by independent educational grants from ineligible companies. A full list of supporters is available here. All accredited content has been developed and delivered in accordance with the ACCME Standards for Integrity and Independence and the criteria of Joint Accreditation for Interprofessional Continuing Education™, and is free of commercial bias.
Important Notice: We have received reports of companies falsely claiming to sell SYNChronicity Conference attendee lists and related services. These solicitations are scams and are not affiliated with SYNChronicity, HealthHIV, HealthHCV, or the National Coalition for LGBTQ Health.
Do not engage with these organizations. For questions about conference communications or vendors, contact us directly.
